Diabetes Mellitus, Hypothalamic Hypoestrogenemia, and Coronary Artery Disease in Premenopausal Women (from the National Heart, Lung, and Blood Institute Sponsored WISE Study)

American Journal of Cardiology

Volumn 102, Issue 2, 2008, Pages 150-154

  Ahmed, Bina ^a   Bairey Merz, C Noel ^a   Johnson, B Delia ^b   Bittner, Vera ^c   Berga, Sarah L ^d   Braunstein, Glenn D ^a   Hodgson, T Keta ^a   Smith, Karen ^e   Shaw, Leslee ^f   Kelsey, Sheryl F ^b   Sopko, George ^g  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^f Atlanta Cardiovasc Res Institute   (United States)

^g NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; ESTROGEN BLOOD LEVEL; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; PREMENOPAUSE; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGE FACTORS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY VESSELS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; ESTROGENS; FEMALE; HUMANS; HYPOTHALAMIC DISEASES; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE (U.S.); PREMENOPAUSE; UNITED STATES;

EID: 46349111711     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.03.029     Document Type: Article

References (29)

1. Davi G., Catalano I., Averna M., Notarbartolo A., Strano A., Ciabattoni G., and Patrono C. Thromboxane biosynthesis and platelet function in type II DM. N Engl J Med 322 (1990) 1769-1774
2. Standley P.R., Ali S., Bapna C., and Sowers J.R. Increased platelet cytosolic calcium responses to low density lipoprotein in type II DM with and without hypertension. Am J Hypertens 6 (1993) 938-943
3. Carmassi F., Morale M., Puccetti R., De Negri F., Monzani F., Navalesi R., and Mariani G. Coagulation and fibrinolytic system impairment in insulin dependent diabetes. Thromb Res 67 (1992) 643-654
4. Goodfellow J., Ramsey M.W., Luddington L.A., and Jones C.J.H. Flow-related endothelial function is impaired in non-insulin dependent diabetes. Circulation 90 suppl I (1994) S513
5. Donahue R.P., Barrett-Connor E., Orchard T.J., and Gutai J.P. Endogenous insulin and sex hormones in atherosclerosis and coronary heart disease. Arteriosclerosis 8 (1988) 544-548
6. Sowers J.R. Insulin and insulin-like growth factor in normal and pathological cardiovascular physiology. Hypertension 29 (1997) 691-699
7. Barrett-Connor E., and Wingard D.L. Sex differential in ischemic heart disease mortality in diabetics: a prospective population-based study. Am J Epidemiol 118 (1983) 489-496
8. Barrett-Connor E.L., Cohn B.A., Wingard D.L., and Edelstein S.L. Why is DM a stronger risk factor for fatal ischemic heart disease in women than in men; the Rancho Bernardo Study. JAMA 265 (1991) 627-631
9. Kannel W.B. Metabolic risk factors for CHD in women: perspective from the Framingham Study. Am Heart J 114 (1987) 413-419
10. Garcia M.J., McNamara P.M., Gordon T., and Kannel W.B. Morbidity and mortality in diabetics in the Framingham population: sixteen year follow-up study. Diabetes Care 12 (1990) 631-654
11. Bairey Merz C.N., Johnson B.D., Sharaf B.L., Bittner V., Berga S.L., Braunstein G.D., Hodgson T.K., Matthews K.A., Pepine C.J., Reis S.E., et al. Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE Study. J Am Coll Cardiol 41 (2003) 413-419
12. Grundy S.M., Pasternak R., and Greenland P. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation 100 (1999) 1481-1492
13. Bairey Merz C.N., Kelsey S.F., Pepine C.J., Reichek N., Reis S.E., Rogers B.J., Sharaf B.L., and Sopko G. The Women's Ischemia Syndrome (WISE) Study: protocol design, methodology and feasibility report. J Am Coll Cardiol 33 (1999) 1453-1461
14. Johnson B.D., Bairey Merz C.N., and Braunstein G.D. Determination of menopausal status in women: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) Study. J Womens Health 13 (2004) 872-887
15. Anderson D.C., Hopper B.R., Lasley B.L., and Yen S.S.C. A simple method for the assay of eight steroids in small volumes of plasma. Steroids 28 (1976) 179-184
16. Kaplan J.R., Adams M.R., Clarkson T.B., and Koritnik D.R. Psychosocial influences on female "protection" among cynomolgus macaques. Atherosclerosis 53 (1984) 283-295
17. Berga S.L., Mortola J.F., Suh G.B., Laughlin G., Pham P., and Yen S.S.C. Neuroendocrine aberrations in women with functional hypothalamic amenorrhea. J Clin Endocrinol Metab 68 (1989) 301-308
18. Berga S.L. Behaviorally induced reproductive compromise in women and men. Semin Reprod Endocrinol 15 (1997) 47-53
19. Lipid Research Clinics Program. The Manual of Laboratory Operations: Lipid and Lipoprotein Analysis (1974), National Institutes of Health, Bethesda, MD 628-678
20. Sharaf B.L., Pepine C.J., Kerensky R.A., Reis S.E., Reicheck N., Rogers W.J., Sopko G., Kelsey S.F., Holubkov R., Olson M., et al. Detailed angiographic analysis of women presenting with suspected ischemic chest pain: pilot phase data from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) Study angiographic core laboratory. Am J Cardiol 87 (2001) 937-941
21. Zhang F., Ram J.L., Standley P.R., and Sowers J.R. 17 Beta-estradiol attenuates voltage-dependant currents in A75 vascular smooth muscle cell line. Am J Physiol 193 (1994) C975-C980
22. Williams J.K., Adams M.R., and Klopfenstein H.S. Estrogens modulated responses to atherosclerotic coronary arteries. Circulation 81 (1990) 1680-1687
23. Horwitz J.B., and Horwitz L.D. Canine vascular tissues are targets for androgens, estrogens, progesterones and glucocorticoids. J Clin Invest 69 (1982) 750-758
24. Louel J.F., LeMay C., and Mauvais-Jarvis F. Antidiabetic actions of estrogen: insight from human and genetic mouse models. Curr Atheroscl Rep 6 (2004) 180-184
25. Kaplan J., Manuck S.B., Anthony M.S., and Clarkson T.B. Premenopausal social status and hormone exposure predict premenopausal atherosclerosis in female monkeys. Obstet Gynecol 99 (2002) 381-388
26. Ehrmann D.A., Barnes R.B., Rosenfield R.L., Cavaghan M.K., and Imperial J. Prevalence of impaired glucose tolerance and DM in women with polycystic ovary syndrome. Diabetes Care 22 (1999) 141-146
27. Dunaif A., Segal K.R., Futterweit W., and Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38 (1989) 1165-1174
28. Burghen G.A., Givens J.R., and Kitabchi A.E. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab 50 (1980) 113-116
29. Sheehan M.T. Polycystic ovarian syndrome: diagnosis and management. Clin Med Res 2 (2004) 13-27